Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)?

被引：5
|
作者：
Falci, C. [1 ]
Basso, U. [1 ]
Fiduccia, P. [1 ]
Brunello, A. [1 ]
Baretta, Z. [1 ]
Solda, C. [1 ]
Lamberti, E. [1 ]
Bozza, F. [1 ]
Capovilla, E. [1 ]
Jirillo, A. [1 ]
Monfardini, S. [1 ]
机构：
[1] IRCCS, IOV, Padua, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 72卷
关键词：
D O I：
10.1016/S1040-8428(09)70042-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 46 条
  • [21] Does screening for frailty with the vulnerable elders survey (VES-13) identify older adults with GU malignancy who benefit most from a consultation in a geriatric oncology clinic?
    AlQurini, Naser M. Kh. M. S.
    Timilshina, Narhari
    Jin, Rana
    Loucks, Allison
    Berger, Arielle
    Romanovsky, Lindy
    Puts, Martine
    Alibhai, Shabbir M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [22] Which better predicts mortality, a prostate cancer (PCa) history or vulnerability on the Vulnerable Elders Survey (VES-13)?: a prospective cohort study.
    Hopkins, H.
    Fan, L.
    Dale, W.
    Hemmerich, J.
    Mohile, S. G.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 117 - 117
  • [23] Which better predicts mortality, a prostate cancer (PCa) history or vulnerability on the Vulnerable Elders Survey (VES-13)? A prospective cohort study.
    Mohile, S. G.
    Hopkins, H.
    Hemmerich, J.
    Fan, L.
    Dale, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Completion of radiotherapy is associated with the Vulnerable Elders Survey-13 score in elderly patients with cancer
    Spyropoulou, Despina
    Pallis, Athanasios G.
    Leotsinidis, Michail
    Kardamakis, Dimitrios
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 20 - 25
  • [25] Pre-injury Vulnerable Elders Survey (VES-13) score facilitates initiation of hospital discharge planning for older trauma patients on admission
    Dzandu, James K.
    Mangram, Alicia J.
    Corneille, Michael G.
    Moyer, Melissa M.
    Stienstra, Arlene
    Collins, Mary
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E52 - E52
  • [26] Implementation of Vulnerable Elders Survey-13 Frailty Tool to Identify At-Risk Geriatric Surgical Patients
    Vernon, Tedrick L., III
    Rice, Andi N.
    Titch, J. Frank
    Hill, Brandyce F.
    Muckler, Virginia C.
    JOURNAL OF PERIANESTHESIA NURSING, 2019, 34 (05) : 911 - +
  • [27] Prevalence and clinical correlates of vulnerable status using the Vulnerable Elders Survey 13 (VES-13) in newly diagnosed adult non-Hodgkin lymphoma (NHL) patients: A LEO cross-sectional analysis.
    Fama, Angelo
    Martin, Peter
    Casulo, Carla
    Nastoupil, Loretta J.
    Thompson, Carrie A.
    Link, Brian K.
    Lossos, Izidore S.
    Kahl, Brad
    Maurer, Matthew
    Allmer, Cristine
    Jaye, David L.
    Feldman, Andew L.
    Slager, Susan L.
    Friedberg, Jonathan W.
    Habermann, Thomas Matthew
    Flowers, Christopher
    Cerhan, James Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Can the Vulnerable Elders-13 Survey (VES-13) scale replace the EuroSCORE scale in predicting complications in patients over 60 years of age undergoing cardiac surgery?
    Kowalczuk-Wieteska, Anetta
    Parys, Monika
    Majchrzyk, Iwona
    Zembala, Michal
    Zembala, Marian
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2019, 15 (02): : 211 - 217
  • [29] G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer
    Shah, Minit
    Noronha, Vanita
    Ramaswamy, Anant
    Gattani, Shreya
    Mokal, Smruti
    Joshi, Amit
    Patil, Vijay
    Menon, Nandini
    Banavali, Shripad
    Badwe, Rajendra
    Prabhash, Kumar
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (05) : 720 - 730
  • [30] The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer
    B. Castagneto
    C. Di Pietrantonj
    I. Stevani
    A. Anfossi
    M. Arzese
    L. Giorcelli
    L. Giaretto
    Medical Oncology, 2013, 30
12345